DJIA 15,914.74 -99.64 -0.62%
NASDAQ 4,283.59 14.83 0.35%
S&P 500 1,851.86 -0.35 -0.02%
market minute promo

Celgene (NASDAQ: CELG)

103.16 2.66 (2.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $103.16 2.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.84
Previous Close $100.50
Daily Range $101.17 - $105.98
52-Week Range $92.98 - $140.72
Market Cap $81.0B
P/E Ratio 21.34
Dividend (Yield) $0.00 (0.0%)
Volume 8,020,423
Average Daily Volume 7,443,902
Current FY EPS $4.19




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Here's Why Juno Therapeutics Dropped 37% in January

Juno Therapeutics kicked off 2016 by losing over a third of its value. Here's why.

INSYS (INSY) Initiates Phase II Study for Infantile Spasms

Actelion (ALIOF) Misses Q4 Earnings, Revenue Estimates

Regeneron Disappoints, The Stock Sells Off: Analysis Of Its Growth Potential

Biotech ETFs Slide As Stocks Report Mixed Q4 Results

Major Biotech Short Interest Continues to Be Mixed

Epizyme's Tazemetostat Gets Orphan Drug Status in the U.S.

3 Biotech Stocks to Buy in a Market Crash

Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.

Biotech ETFs Slide as Stocks Report Mixed Q4 Results

3 High-Growth Stocks You Don't Need to Babysit

Not every growth company is necessarily a risky bet.

See More CELG News...

CELG's Top Competitors

CELG $103.16 (2.65%)
Current stock: CELG
AMGN $144.81 (1.15%)
Current stock: AMGN
GILD $87.77 (0.60%)
Current stock: GILD
$0.00 (0.00%)
Current stock: